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of this complex with trypsin removes the membrane fragments 
from T. tyrosinase, and the T.-trypsin enzyme now again be-
haves electrophoretically identical to T ,. T hese isozymes are 
now only distinguishable by virtue of the fact that T, is asso-
ciated with blocking factor , while T4-trypsin still can be shown 
to contain conversion factor (s), in spite ofthe trypsin treatment. 
We recognize that additional experiments are necessary in order 
to prove these points unequivocaUy, and our major immediate 
goal is to elucidate the structuxes and modes of action of these 
regulatory factors. 
We thank Thomas Ekel, Paul Montague a nd Alan Bergstrom fo r 
their capable assistance. 
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The comparative effects of the tumor promoter an-
thralin and its an a log, d anthron, on semiconservative 
DNA replica tion and DNA r epair synthesis w ere s tudied 
in cultured human cells . Hr omodeoxyuridine was u sed 
as den sity la bel together with "H-th ymidine to dis tin-
guish replica tion from repair synthesis in isopycnic CsCI 
gradien ts. Anthralin at 1.1 /LM inhibited r eplication in 
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T98G cells by 50%. In cells treated with 0.4 or 1.3 /LM 
a nthralin an additive effect was observed on the inhibi-
tion of replication by ultraviolet light (254 nm). In cells 
irradiated with 20 J/m2, 2.3 /LM anthralin was r equired 
to inhibit repair synthesis by 50%. Thus ther e was no 
selective inhibitory effect of anthralin on repair synthe-
sis . Danthron exhibited no de t ectable effect on either 
Sciences, Stanford University , Stanford, CA 94305. 
Abbreviations: 
Brd Urd : bromodeoxyuridine 
DMSO: dimethylsul foxide 
dThd: deoxythymidine 
Frd Urd: tluorodeoxyuridine 
PBS: phosphate-buffered saune 
TPA: 12-0-tetradecanoyl phorbol-13-acetate 
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semiconservative replication or repair synthesis at con-
centrations below about 5.0 .aM. Neither compound stim-
ulated repair synthesis in the absence of ultraviolet ir-
radiation. Thus, anthralin and danthron do not appear 
to react with DNA to form adducts that are subject to 
excision repair. Although both compounds appear to 
intercalate into supercoiled DNA in vitro to a limited 
extent, the degree of unwinding introduced by the re-
spective drugs does not correlate with their relative 
effects on DNA synthesis in vivo. Therefore the inhibi-
tory effect of anthralin on DNA replication and repair 
synthesis in T98G cells does not appear to result from 
the direct interaction of the drug with DNA. 
Tumor promoters constitute a diverse group of compounds 
that exhibit littl e or no carcinogenic activity but which greatly 
potentiate the rate and/ or final extent of tumor induction by 
primary carc inogens [1,2). Several models h ave been proposed 
to account for this phenomenon [3] but its molecular basis 
remains obscure. One model, based upon the observation that 
tumor promoters inhibited UV-stimulated repair synthesis in 
cultured human lymphocytes, s uggested that inhibition of DNA 
repair played a major role in tumor promotion [4). This hy-
pothesis h as been challenged by sub equent work showing 
general inhibition of DNA metabolism rather th an specific 
inhibition of DNA repau' synthesis by tumor promoters [5,6). 
Anthralin (1, 8-dihydroxy-9-anthrone) is the most potent of 
the nonphorbol ester tumor promoters although its activity i 
relatively weak compared to the prototype promoter I2-0-tetra-
decanoyl-phorbol-I3-acetate (TPA) [7]. However it is of partic-
ular interest because of its clinical application in th e treatment 
of psoriasis [8]. Danth.ron (1, 8-dihydroxy-anthraquinone) is a n 
oxidation product of anthralin that exhibits no tumor promoting 
activity [7,9]. We have compared the effects of each compound 
on semiconservative DNA replication and repau' synthesis in 
cultured human cells us ing the bromodeoxyw'idine/ 3H-thymi-
dine labeling procedure to distinguish replication from r epair 
synth esis in isopycnic CsCI gradients [10). We have also com-
pared the ability of these compounds to intercalate into super-
coiled DNA. 
MA TERIALS AND METHODS 
Materials 
Anthralin, obtained from lCN Pharmaceuticals, Inc. (Plainview, 
N.Y.), was analyzed by high-performance liquid chromatography and 
found to contain less than 5% danthron and anthralin dimer, the 
principal contaminants of commercial anthralin preparations. Dan-
thron and ethidium bromide were obtained from Sigma Chemical Co. 
(St. Louis, Mo.). ColEl plasmid DNA was generously provided by P . 
Seawell in this laboratory . Purified nicking-closing enzyme (DNA to-
poisomerase) from AgrobacLeriwn twnefadens [11.] was obtained from 
Bethe da Reseal"ch Laboratories (Rockville, MD.). Proteinase K was 
obtained from Beckman Instruments, Inc., (Palo Alto, Ca.). Agarose 
was obta ined from Bio-Rad Laboratories (Richmond , Ca.). 
Cell Culture 
T98G, a continuous, contact- inh ibited human cell line [12] obtained 
from G. Stein, University of Colorado, was grown at 37° in Eagle's 
minimum essential medium with Earle's salts supplemented with ]0% 
fetal calf serum in a humidified 5% CO. atmosphere. 
Drug Treatment and Irradiation 
Freshly prepared anthralin and danthron solu tions (1 mg/ ml in 
DMSO) were diluted into growth medium and applied immediate ly in 
5 ml a liquots to cells grown in 100 mm Petri dishes and washed with 
warm phosphate-buffered saline (PB : 0.14 M NaCl, 3 mM KCl, 8 mM 
Na"HPO." 13 mM KH. PO .. ·2H.O, pH 7.5). The final DMSO concentra-
tion was usually 0.1% but occasionally 0.3%. No cytotoxic effects of 
either drug were observed at concentrations below 10 /-1M. Anthralin 
concentrations above 10 ~tM resulted in 5-10% loss of cells from the 
dishes. After 30 min the cells were washed twice with PBS and irrad i-
ated at 254 nm with a Westinghouse IL 782-30 germicidal lamp. T he 
output of this lamp was 0.33 J / m"!sec as measured by an IL 254 
Germicidal Photometer (International Light, Newburypost, Mass.) . 
Semicoll seruatiue DNA Replication an.d Repair Syn.thesis 
Semiconservative DNA replication and repair synthesis were mea-
ured us described [10,13]. In all experiments the T98G cells were used 
5 days afte r seeding at 1:3 and were approaching confluence. Cells 
labeled with 3tp were incubated in medium containing 10 /-1M BrdUrd 
and I /-1M FrdUrd for 1 to 2 hr prior to drug treatment and irradiation. 
The BrdUrd- and FrdUrd-containing medium was then restored to the 
plates with the addition of freshly-diluted anthralin or danthron plus 
2.5 /-ICi/ml CHldThd (New England Nuclear Corp., 50.5 Ci/mmole), 
and the cells were incubated for 4 hI' at. 37°C. The cells were lysed with 
sodium lauryl sulfate and the Iysat.es were incubated with proteinase K 
for ! hr at 50°C. The hybrid DNA was then separated from light 
parental DNA by neutral CsCI density gradient cent.rifugation as de-
scribed [10,13]. Semiconservative replication was quantitated by mea-
sUl"ing the amount of ["H]dThd incorporated into acid-preciilitable 
DNA banding at the hybrid-density position. The :JH incorporation in 
each sample was normalized to that of a control gradient derived from 
untreated cells by using the ratio of :I"p in parental-density DNA of the 
control and sa mple gradients. Fractions containing the light pru'ental-
density DNA were pooled and the DNA rebanded in alkaline CsCI as 
described [10,13]. The "H to :J2p ralio determined from these gradients 
was multiplied by the "2p specific activity of the DNA and the amount 
of repair synthesis expressed as "H incorporated per /-Ig DNA. The 3"p 
specific activi ty of the DNA was determined as described [14]. 
En zymatic R elaxation of Supercoiled DNA 
ColE! ; DNA was treated in 20 mM Tris-HCI, pH 7.8: 2 mM MgCh: 7 
mM 2-mercaptoethanol. Freshly prepared solutions of anthl"al in or 
danthron were diluted int.o reaction mixtures containing approximately 
0.5 ~tg of ColEI DNA. In these experiments anthl"alin and danthron 
were dissolved in acetone before dilution; ethidium bromide was dis-
solved in double-distilled water. A volume of acetone equivalent to that 
used in the anthralin or danthron-treated samples was added to control 
and ethidium bromide-treated DNA samples; the final volume (exclud-
ing acetone) in all cases was 40 /-II. Nitrogen was bubbled through the 
reaction mixtures to remove acetone; after equilibration at 37°C for J 
min, 3 units of A. tumefa.ciens nicking-closing enzyme [ll] were added 
and the mixtures were incubated for 1 hl" at 37°C. The reactions were 
terminated by dilution to 0.2 ml with warm 10 mM Tris, pH 8.0: 1 mM 
EDTA. The DN A was extracted t.w ice with chloroform: isoamyl alcohol 
(20:1) at 37°C to remove the drugs and enzyme. The samples were 
reduced in volume to 30 ~L1 under a nitrogen stream, and prepal'ed for 
electrophoresis by adding 10 /-II of bromophenol blue (25 /-Ig! ml in 50 
mM Tris: 20 MM EDTA: 40% sucrose). All manipulations were per-
formed under yellow light. 
Gel Electrophoresis 
Electrophoresis of DNA was performed using a procedure modified 
{i'om Keller [15]. Agru'ose gels (1.4 % weight/ volume) were formed 
between 2 glass plates of a vertical slab gel apparatus (14 x 12 x 0.3 cm). 
The electrophoresis buffer was 40 mM Tris-HCl, pH 7.9: 5 mM sodium 
acetate: 1 mM Na~-EDTA and was circulated between the electrode 
comprutments at a rate of 4-6 ml/min. E lectrophoresis was cruTied out 
at 4 V /cm for 14 hI' at room temperatme. The gels were then incubated 
with ethidium bromide (0.5 fLg/ mJ in electrophoresis buffer) for 1 lu' 
and photographed. 
RESULTS 
Inhibition of DNA Synthesis by Anthralin or Danthron 
Protiles of a representative set of neutral CsCI density gra-
dients used to resolve DNA made by normal semiconservative 
replication from that made by repair synthesis are depicted in 
Fig 1. In aU protiles the dense, hybrid-DNA was well separated 
from the light, parental-density DNA. The amount of :JH in 
hybrid DNA in the gradients is a measure of t he amount of 
replication; compared to that in the untreated control (Fig Ia) 
such replication was mru'kedly reduced in cells treated with 
a ntlu-alin (Fig 16) or uTadiated with 254 nm light (Fig Ie). 
Replication in UV uTadiated cells was fmther suppressed by 
treatment with a nthralin (Fig Id) . 
The amount of JH in the light density DNA is a measure of 
repai.r synthesis; none was detected in untreated cells (Fig Ia) 
or in cells treated only with anthralin (Fig 1b). The repaiT 
synthesis observed in cells uTadiated with UV light (Fig Ie) was 
noticeably reduced when the cells were also treated with an-
thralin (Fig Id). No repair synthesis was detected in unu'ra-
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FIG 1. Hadioactivity profiles of neutral CsCI gradients of DNA from 
T98G cells treated with anthralin and/or 254 nm UV. T98G cells 
labeled with :J2p were incubated with ~H-dThd (2.5 fLCi/ml) for 4 hr at 
37°C (a) after no anthralin or UV treatment, (b) after anthralin (1.3 
fLM) treatment only, (c) after UV irradiation only (20 J/m2) and (d) 
after anthralin (1.3 fLM) and UV (20 J/m2) treatment. :J2P-labeled 
parental DNA (A-A) bands at the light density position; "H-Iabeled 
DNA (0-0) bands at the hybrid density (semiconservative replica-
tion) and light density (repair synthesis) positions. Density increases to 
the left. 
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FIG 2. Hadioactivity profiles of alkaline CsCI gradients of fractions 
containing parental-density DNA (fractions 20-26) isolated from 
the neutral CsCI gradients shown in Fig 1 (c) and (d). ~2P-labeled 
(A-A) and ;lH-labeled (0-0), single-stra nded DNA band at the same 
density in gradients from (a) cells inadiated with 20 J/m' or (b) cells 
treated with anthralin (1.3 fLM) and UV (20 J/m2). 
diated cells treated with either 0.4 to 22 /1.M anthralin or 0.4 to 
21 J1.M danthron. This suggests that neither compound reacts 
with DNA in vivo to form a detectable frequency of adducts 
repaired by the excision repair system. To exclude any contri-
bution of residual replication to the quantitation of repair 
synthesis, fractions containing parental-density DNA were re-
banded in alkaline CsCI as shown in Fig 2. The 3H incorporated 
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in these gradients represents only repair synthesis since the "H-
labeled DNA bands at the same density as 32P-Iabeled parental 
DNA. 
Figure 3 summarizes the effects of anthralin and danthron on 
semiconservative replication and repai.r synthesis over a 50-fold 
range of concentration. Danthron at concentrations below 
about 20 flM had little or no effect on either replication or repair 
synthesis; anthralin inhibited both, although replication was 
inhibited to a slightly greater extent than repair synthesis at all 
concentrations. Thus there was no selective inhibitory effect of 
anthralin on repair synthesis. 
Table I summarizes data on the combined effect of anthralin 
and 254 nm UV irradiation on semiconservative replication. In 
cells treated with 0.4 or 1.3 flM anthralin after various doses of 
UV, the inhibition of replication by anthralin was approxi-
mately additive to that inhjbition due to the UV. For example, 
when given separately, 1.3 flM anth.ralin and 5 J/m2 reduced 
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FIG 3. Inhibition of semiconservative replication in unirradiated 
cells (open symbols) and repair synt hesis in cells irradiated with 20 J ! 
m2 (closed symbols) by anthra lin (0 , e) or danthron (0, .). Acetone 
was used as the solvent for anthralin in one experiment (6, A). Hepli-
cation and repair synthesis were quantitated as described in Materia ls 
and Methods. Replication was norma lized to the amount of ~H incor -
porated into hybrid-density DNA from untreated cells. Repair synthesis 
CH cpm/~ DNA) was normalized to the value for cells irradiated with 
20 J/m". The concentration scale is logarithmic. 
TABLE I. Combined effect of anthralin and 254 nm UVon 
sem.iconservative DNA replication. in T98G cells" 
Anthralin (/lM) UV (J i m' ) Replication (%) Expected Value" 
0.0 o. 100 
0.4 0 89' 
0.0 5 48' 
0.4 5 35'· 43 
0.0 10 30' 
0.4 10 24 ' 27 
0.0 15 24 ' 
0.4 15 19' 22 
1.3 0 53 
0.0 5 54 
1.3 5 32 29 
0.0 10 35 
1.3 10 22 18 
" Heplication in cells treated w.ith anthralin and/or UV was determined 
from the incorporation of ["H]dThd into acid-precipitable DNA band-
ing at hybrid-density in neutral CsCI, and compared to the incorpora-
tion into hybrid-density DNA in a control gradient with untreated cells. 
The ;lH incorporation in each gradient was corrected for slight varia-
tiol1s «10%) in DNA conten t by using the ratio of :J2p in paJ·ental-
density DNA of the control and sample gradients. A minimum of 10,000 
cpm were present in hybrid-density DNA of the control gradients. 
" Calculated as the product of the individual effects on replication of 
anthralin and UV treatments given separately, e.g., antl1J"alin (0.4 fLM) 
X UV (5 J/m' ) = 0.89 X 48 = 43%. 
r Average of 2 independent experiments. 
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replication to 53% and 54% of the control value, respectively. 
The combined effect of these 2 treatments reduced replication 
to 32% of the control value, in reasonable agreement with 29%, 
the product of the individual contributions of anthralin and UV 
(Table I). The residual replication after UV irradiation was 
thus flither suppressed by anttu'alin treatment to an extent 
commensurate with that seen in unirradiated cells. The levels 
of repau' synthesis in UV -uTadiated cells treated with antlu-aJin 
were consistently below those in UV -irradiated cells not treated 
with anttu'alin, and the extent of inhibition observed with a 
given anthl'alin concentration was approximately the same for 
UV doses ranging from 5 to 20 J/m~ (data not shown). Elimi-
nating the 30-min treatment with antiu-alin prior to irradiation 
resulted in levels ofreplication and repair synthesis which were 
only slightly higher than the corresponding values obtained 
using the standard procedure. This suggests that any residual 
anthralin present in cells treated with the dJ'ug before irradia-
tion did not substantially influence the effective UV dose. The 
ability of anttu'alin to inhibit either replication or rep ail' syn-
thesis was markedly reduced when the dJ'ug was held in growth 
medium for 30 min at 37°C prior to treating the cells. This 
suggests that inactivation of anttu'alin occurs rapidly when the 
drug is diluted into the cul ture medium. 
In the foregoing experiments anthralin was dissolved in 
DMSO before being diluted into growth medium. In the inter-
calation experiments to foUow, anttu'alin was dissolved in ace-
tone. To ensure that comparisons between the two sets of data 
were valid and that solvent effects on anthralin stability were 
minimal, the DNA synthesis experiments were repeated at an 
anthralin concentration of 1.3 flM using acetone as the solvent. 
As shown in Fig 3, both replication and repail' synthesis were 
inhibited to approximately the same extent when either acetone 
or DMSO was used as the solvent. 
Intercalation into Supercoiled DNA 
Earlier experiments that measmed changes in the visible 
absorption spectrum of anttu'alin solutions in the presence of 
DNA have been interpreted as evidence for intercalative bind-
ing of anttu'alin to DNA [16,17]. To reevaluate the comparative 
ability of anthralin and danthron to intercalate into DNA, 
supel'coiled CoIE1 DNA was enzymatically relaxed in the pres-
ence or absence of drug and analyzed by electrophoresis on 
agarose gels. Enzymatic relaxation of supercoiled DNA in the 
absence of an intercalating agent results in discrete DNA to-
poisomers that form a Boltzmann distribution centered about 
an average value of iX, the topological windil1g number [18]. 
When relaxation is carried out in the presence of an intercalat-
ing agent such as ethidium bromide the distribution of topoiso-
mers produced is centered about an altered ii, whose magnitude 
depends upon the amount of agent intercalated per DNA 
molecule, and thus, below saturating values, upon its concen-
tration. After removal of the agent, ii can be determined by 
electrophoresis of the DNA in appJ'opriate agarose gels in which 
the change in ii confers a detectable change in electrophoretic 
mobility [15,19]. The results of such an experiment using ethid-
ium bromide, anthralin, and dantlu'on (Fig 4) show that both 
anthralin and danthron do intercalate into DNA to a limited 
extent. Untreated CoLEl DNA (Lane A) was resolved into two 
well separated species, supercoiled DNA (Form I) of native 
superhelicity that migrated rapidly to a position near the bot-
tom of the gel, and nicked circular DNA (Form II) that migrated 
slowly and remained neru' the top of the gel. The pattern for 
DNA relaxed in the absence of any drugs (Lane B) showed the 
conversion of the original Form I DNA of high superhelicity to 
a distribution of topoisomers as discussed above. T he pattern 
for the DNA relaxed ill the presence of 0.25 flM ethidium 
bromide (Lane C) was similar, except tha t the center of the 
distribution of topoisomers was shifted to higher electrophoretic 
mobility, as expected. The patterns for DNA relaxed in the 
presence of 0.4 f.lM anttu'alin (Lane D) or 0.4 f.lM danttu'on (Lane 
A 8 c o E 
I 
FIG 4. Electrophoresis patterns of DNA topoisomers generated by 
treating supercoiled ColEl plasmid DNA with nicking-closing enzyme 
from A. tu.m.efaciens. Purified ColE 1 DNA was elecb'ophoresed thl"ough 
agarose gels before (Lane A) and after treatment wi th an excess of 
nicking-closing enzyme in the absence of drugs (Lane B) , or after 
treatment in the presence of 0.25 fLM ethidium bromide (Lane C) , 0.4 
fLM antl11'alin (Lane D) , or 0.4 fLM danthron (Lane E). 
E) showed a similru' shift in the center of the distribution, when 
compared to the control (Lane B). The shift was smaller than 
that observed in DNA relaxed in the presence of ethidium 
bromide. When 2 flM anthralin or danthron was used the shift 
increased by about a factor of 2 and was again of the same 
magnitude for the two dJ·ugs. Thus dantlu-on, which is much 
less effective in inhibiting DN A synthesis in vivo than anttu'alin, 
apperu's to intercalate into DNA as effectively as anttu·alin. 
DISCUSSION 
Semiconservative DNA replication can be distinguished from 
repail' synthesis by using the BrdUrd density labeling technique 
[10]. This method has the advantage that both processes can 
be studied quantitatively in the same population of cells. Ex-
periments that measw-e repair synthesis in cells treated with 
hydroxyurea to suppress replication lack this advantage, and 
are complicated by the fact that hydJ'oxymea also affects the 
repair process [20]. We have used the BrdUrd method to test 
the hypothesis that tumor promoters such as antlu-alin exert 
their effects by specifically inhibiting DNA repail·. TIllS hypotl1-
esis had been based upon the observation that several tumor 
promoters including anthralill inhibited the mcorporation of 
eH]thymidine after UV il'radiation in human lymphocytes in 
the presence of hydJ'oxyurea [4]. In that study however , t he 
effects of promoters on semiconservati.ve replication were not 
determined. Om studies show that anthralin inhibits both rep-
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lication and repair synthesis, and thus that its effects represent 
a general inhibition of DNA synthesis rather than specific 
inhibition of repair. Our results are in agreement with those of 
Cleaver and Painter [5] although they presented only limited 
quantitative data on anthralin as part of a survey of a large 
number of compounds, and used concentrations of anthralin 
(0.2-0.4 mM) that exceed the limit of solubility of anthralin in 
culture medium (less than 0.1 mM [Su-Chin Liu, personal 
communication]). Experiments by Poirier, De Cicco, and Lie-
berman [6], in which N-acetoxy-2-acetylaminofluorene was 
used to stimulate repair synthesis in human fibroblasts treated 
with hydroxyurea, also revealed no preferential inhibition of 
DNA repair by anthralin. The biological activity of anthralin, 
both as a tumor promoter and as an inhibitor of DN A synthesis, 
apparently requires specific features of the anthralin molecule 
since danthron, a closely related analog that is not a tumor 
promoter [7] exhibited little effect on either mode of DNA 
synthesis at concentrations at which significant inhibition by 
anthralin was observed. 
Although danthron did not inhibit DNA synthesis as effec-
tively as anthralin, it appeared to intercalate into DNA to 
approximately the same extent as anthralin (Fig 4). This result 
suggests that intercalation is not the mechanism by which 
anthralin inhibits DNA synthesis in vivo, although we cannot 
rule out the possibility that intercalated anthralin molecules 
inhibit DNA synthesis more effectively than intercalated dan-
thron molecules. Moreover, it is possible that, despite their 
structural similarity [6] , a difference in the unwinding angle of 
these two compounds could affect the mobility shift and com-
plicate quantitative comparisons between the two drugs. How-
ever, we consider it unlikely that such differences would be 
sufficient to account for the· qualitatively different effects of 
anthralin and danthron on DNA synthesis in vivo. It is also 
unlikely that these compounds would participate in non-inter-
calative binding sufficient to cause the degree of unwinding that 
we observed. 
Anthralin and 254 nm UV interact with one another in an 
approximately additive manner to suppress semiconservative 
replication, suggesting that their inhibitory effects are mediated 
by different mechanisms. Since anthralin alone did not stimu-
late repair synthesis and since it inhibited repair synthesis in 
cells irradiated with UV doses that did not saturate their repair 
capacity, it is probable that anthralin treatment alone or in 
conjunction with UV does not form significant numbers of 
covalent adducts to DNA in vivo. Thus the mechanism by 
which anthralin interacts with UV to suppress replication prob-
ably does not involve direct blockage of replication forks by 
anthralin-DNA adducts, as is thought to occur for UV-induced 
pyrimidine dimers [20]. However, we cannot exclude the pos-
sibility that adducts are formed that are not substrates for 
excision repair, and thus not detectable in our experiments. 
The fact that anthralin inhibited repair synthesis to approxi-
mately the same extent after UV doses ranging from 5 to 20 Jj 
m~ is consistent with the hypothesis that anthralin has a general 
effect on cellular metabolism rather than a specific effect on 
repair synthesis. This interpretation is supported by the finding 
that anthralin also inhibits RNA and protein synthesis [6]. The 
exact mechanism by which anthralin inhibits DNA synthesis 
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in vivo remains unclear but apparently is not the result of a 
direct interaction of the drug with DNA. 
We appreciate the helpful discussions and critical reading of Lhe 
manuscript by Drs. Ann Ganesan and Charles Allen Smith. 
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